Homotypic and Heterotypic Neutralization Determinants of Bluetongue Virus Serotype 17

Corinne M. Pierce, Paul V. Rossitto, Nigel J Maclachlan

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Homotypic and heterotypic neutralization determinants of bluetongue virus serotype 17 (BTV-17) were investigated with a panel of five neutralizing monoclonal antibodies (MAbs). One MAb (MAb 034) was originally raised to BTV serotype 10 (BTV-10) but also neutralizes BTV-17 (P. V. Rossitto, and N. J. MacLachlan, 1992, J. Gen. Virol. 73, 1947-1952). Competitive binding studies indicate that the MAbs recognize at least two epitopes on the neutralizing outer capsid protein VP2 of BTV17. The MAbs were used to select neutralization-resistant variant [escape mutant (EM)] viruses and to determine the phenotypic characteristics of these EM viruses by immunoprecipitation and neutralization assays. Sequencing of the L2 gene, which encodes VP2, identified mutations responsible for the altered phenotypic properties exhibited by each EM virus. Four amino acids in three regions of VP2 are critical to the expression of the epitopes recognized by the panel of neutralizing MAbs. Amino acid 199 affects the binding of MAbs 17.82, 17.83, and 17.813; amino acid 213 affects the binding of MAb 17.85; and amino acids 327 and 582 synergistically affect the binding of MAb 034. Similarly, amino acids 327 and 402 synergistically affect the binding of MAb 034 to BTV-10 (C. O. DeMaula, H. W. Heidner, P. V. Rossitto, C. M. Pierce, and N. J. MacLachlan, 1993, Virology 195, 292-296), suggesting that the neutralizing epitope common to BTV-10 and BTV17 has a similar location in VP2 of these two antigenically distinct viruses.

Original languageEnglish (US)
Pages (from-to)263-267
Number of pages5
JournalVirology
Volume209
Issue number1
DOIs
StatePublished - May 10 1995

Fingerprint

Bluetongue virus
Monoclonal Antibodies
Amino Acids
Viruses
Epitopes
Neutralizing Antibodies
Virology
Competitive Binding
Capsid Proteins
Immunoprecipitation
Serogroup
Mutation
Genes

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

Homotypic and Heterotypic Neutralization Determinants of Bluetongue Virus Serotype 17. / Pierce, Corinne M.; Rossitto, Paul V.; Maclachlan, Nigel J.

In: Virology, Vol. 209, No. 1, 10.05.1995, p. 263-267.

Research output: Contribution to journalArticle

Pierce, Corinne M. ; Rossitto, Paul V. ; Maclachlan, Nigel J. / Homotypic and Heterotypic Neutralization Determinants of Bluetongue Virus Serotype 17. In: Virology. 1995 ; Vol. 209, No. 1. pp. 263-267.
@article{993b624f8e6c41ad89dd0c921685408b,
title = "Homotypic and Heterotypic Neutralization Determinants of Bluetongue Virus Serotype 17",
abstract = "Homotypic and heterotypic neutralization determinants of bluetongue virus serotype 17 (BTV-17) were investigated with a panel of five neutralizing monoclonal antibodies (MAbs). One MAb (MAb 034) was originally raised to BTV serotype 10 (BTV-10) but also neutralizes BTV-17 (P. V. Rossitto, and N. J. MacLachlan, 1992, J. Gen. Virol. 73, 1947-1952). Competitive binding studies indicate that the MAbs recognize at least two epitopes on the neutralizing outer capsid protein VP2 of BTV17. The MAbs were used to select neutralization-resistant variant [escape mutant (EM)] viruses and to determine the phenotypic characteristics of these EM viruses by immunoprecipitation and neutralization assays. Sequencing of the L2 gene, which encodes VP2, identified mutations responsible for the altered phenotypic properties exhibited by each EM virus. Four amino acids in three regions of VP2 are critical to the expression of the epitopes recognized by the panel of neutralizing MAbs. Amino acid 199 affects the binding of MAbs 17.82, 17.83, and 17.813; amino acid 213 affects the binding of MAb 17.85; and amino acids 327 and 582 synergistically affect the binding of MAb 034. Similarly, amino acids 327 and 402 synergistically affect the binding of MAb 034 to BTV-10 (C. O. DeMaula, H. W. Heidner, P. V. Rossitto, C. M. Pierce, and N. J. MacLachlan, 1993, Virology 195, 292-296), suggesting that the neutralizing epitope common to BTV-10 and BTV17 has a similar location in VP2 of these two antigenically distinct viruses.",
author = "Pierce, {Corinne M.} and Rossitto, {Paul V.} and Maclachlan, {Nigel J}",
year = "1995",
month = "5",
day = "10",
doi = "10.1006/viro.1995.1253",
language = "English (US)",
volume = "209",
pages = "263--267",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Homotypic and Heterotypic Neutralization Determinants of Bluetongue Virus Serotype 17

AU - Pierce, Corinne M.

AU - Rossitto, Paul V.

AU - Maclachlan, Nigel J

PY - 1995/5/10

Y1 - 1995/5/10

N2 - Homotypic and heterotypic neutralization determinants of bluetongue virus serotype 17 (BTV-17) were investigated with a panel of five neutralizing monoclonal antibodies (MAbs). One MAb (MAb 034) was originally raised to BTV serotype 10 (BTV-10) but also neutralizes BTV-17 (P. V. Rossitto, and N. J. MacLachlan, 1992, J. Gen. Virol. 73, 1947-1952). Competitive binding studies indicate that the MAbs recognize at least two epitopes on the neutralizing outer capsid protein VP2 of BTV17. The MAbs were used to select neutralization-resistant variant [escape mutant (EM)] viruses and to determine the phenotypic characteristics of these EM viruses by immunoprecipitation and neutralization assays. Sequencing of the L2 gene, which encodes VP2, identified mutations responsible for the altered phenotypic properties exhibited by each EM virus. Four amino acids in three regions of VP2 are critical to the expression of the epitopes recognized by the panel of neutralizing MAbs. Amino acid 199 affects the binding of MAbs 17.82, 17.83, and 17.813; amino acid 213 affects the binding of MAb 17.85; and amino acids 327 and 582 synergistically affect the binding of MAb 034. Similarly, amino acids 327 and 402 synergistically affect the binding of MAb 034 to BTV-10 (C. O. DeMaula, H. W. Heidner, P. V. Rossitto, C. M. Pierce, and N. J. MacLachlan, 1993, Virology 195, 292-296), suggesting that the neutralizing epitope common to BTV-10 and BTV17 has a similar location in VP2 of these two antigenically distinct viruses.

AB - Homotypic and heterotypic neutralization determinants of bluetongue virus serotype 17 (BTV-17) were investigated with a panel of five neutralizing monoclonal antibodies (MAbs). One MAb (MAb 034) was originally raised to BTV serotype 10 (BTV-10) but also neutralizes BTV-17 (P. V. Rossitto, and N. J. MacLachlan, 1992, J. Gen. Virol. 73, 1947-1952). Competitive binding studies indicate that the MAbs recognize at least two epitopes on the neutralizing outer capsid protein VP2 of BTV17. The MAbs were used to select neutralization-resistant variant [escape mutant (EM)] viruses and to determine the phenotypic characteristics of these EM viruses by immunoprecipitation and neutralization assays. Sequencing of the L2 gene, which encodes VP2, identified mutations responsible for the altered phenotypic properties exhibited by each EM virus. Four amino acids in three regions of VP2 are critical to the expression of the epitopes recognized by the panel of neutralizing MAbs. Amino acid 199 affects the binding of MAbs 17.82, 17.83, and 17.813; amino acid 213 affects the binding of MAb 17.85; and amino acids 327 and 582 synergistically affect the binding of MAb 034. Similarly, amino acids 327 and 402 synergistically affect the binding of MAb 034 to BTV-10 (C. O. DeMaula, H. W. Heidner, P. V. Rossitto, C. M. Pierce, and N. J. MacLachlan, 1993, Virology 195, 292-296), suggesting that the neutralizing epitope common to BTV-10 and BTV17 has a similar location in VP2 of these two antigenically distinct viruses.

UR - http://www.scopus.com/inward/record.url?scp=0029020132&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029020132&partnerID=8YFLogxK

U2 - 10.1006/viro.1995.1253

DO - 10.1006/viro.1995.1253

M3 - Article

C2 - 7538255

AN - SCOPUS:0029020132

VL - 209

SP - 263

EP - 267

JO - Virology

JF - Virology

SN - 0042-6822

IS - 1

ER -